BCG bladder instillation therapy is widely accepted and used, worldwide, for prophylaxis against recurrent non-muscle invasive bladder cancer. Despite its efficacy, various reports have documented the therapy's side-effects.1,2 The most common complications include bladder irritation, fever and gross hematuria; most are considered to be BCG reactions. Systemic infections also occur in some cases that are difficult to diagnose, including local infections not centered in the urinary bladder.We report a patient who presented with an infectious aortic aneurysm 1 year after BCG intravesical instillation therapy for prevention of recurrent non-muscle invasive bladder carcinoma. This complication is extremely rare in the urology domain, but several cases have been reported by cardiovascular surgeons.3-5 The patient, a 72-year-old man with multiple non-muscle invasive bladder carcinomas, was treated using transurethral resection. There was no evidence of thoracic or abdominal aorta aneurysms before BCG instillation (Fig. 1a). Subsequently, BCG (Tokyo 172 strain) bladder instillation therapy (80 mg/instillation, eight instillations) was administered. Before BCG instillation, his laboratory data were normal, including renal and liver functions. He experienced only one night low-grade fever between the first and fifth instillations. Slight bladder irritation symptoms occurred after the seventh instillation. There were no systemic symptoms.One year post-treatment, the patient suffered from constipation, and an abdominal mass was detected by ultrasound. CT showed thoracic (Fig. 1b) and abdominal aortic aneurysms (Fig. 1c). These were diagnosed as infectious aneurysms, because the patient's C-reactive protein levels were slightly increased to 2.44. Other laboratory data were within normal ranges. Furthermore, evidence of prostatitis was not observed in his CT scans, before or after the diagnosis.After diagnosing infectious aneurysms, antibiotics (meropenem and vancomycin) were given, without clinical effect within 2 weeks of the start of treatment. Subsequently, the abdominal aortic aneurysm was replaced with a synthetic graft. A histological examination of the resected aorta showed granulomatous inflammation, and Ziehl-Neelsen staining showed a small number